Bruce Keyt - Apr 6, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Scientific Officer
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Apr 6, 2022
Transactions value $
-$60,175
Form type
4
Date filed
4/8/2022, 07:24 PM
Previous filing
Apr 1, 2022
Next filing
May 17, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Options Exercise $2.33K +2.5K +6.25% $0.93* 42.5K Apr 6, 2022 Direct F1
transaction IGMS Common Stock Sale -$62.5K -2.5K -5.88% $25.00 40K Apr 6, 2022 Direct F1
holding IGMS Common Stock 1.01K Apr 6, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Options Exercise $0 -2.5K -1.83% $0.00 134K Apr 6, 2022 Common Stock 2.5K $0.93 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 The shares are held directly by the reporting person's spouse.
F3 The shares subject to the option are vested and exercisable as of the date hereof.